Ultragenyx Pharmaceutical Inc. buy Robert W. Baird
Start price
30.01.24
/
50%
€40.80
Target price
30.01.25
€62.74
Performance (%)
-5.88%
Price
20.05.24
€38.40
Summary
This prediction is currently active. With a performance of -5.88%, the BUY prediction for Ultragenyx Pharmaceutical Inc. by Robert_W__Baird is down slightly. This prediction currently runs until 30.01.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 1.053% | 1.053% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Robert_W__Baird for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Robert W. Baird from $57.00 to $68.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat